较低的ANXA3水平可能与严重抑郁症有关
Mine Büşra Bozkürk1, Kadir Özdel2, Bilge Ozan Çiçek1
1Ankara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.
Life (Basel, Switzerland)
|September 27, 2025
概括
大型抑郁症 (MDD) 患者的血清附件A3 (ANXA3) 水平显著降低. 较低的ANXA3,以及高的中性粒细胞与淋巴细胞比率和葡萄糖问题,预测了更大的抑郁症严重程度,这表明ANXA3是潜在的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床精神病学 临床精神病学
背景情况:
- 素A3 (ANXA3) 是一种结合蛋白,参与炎症和膜脂代谢.
- 在一些精神疾病中观察到改变的ANXA3水平,但其在主要抑郁症 (MDD) 中的作用尚不清楚.
研究的目的:
- 为了比较MDD患者和健康对照者的血清ANXA3水平.
- 调查血清ANXA3水平与MDD中抑郁症严重程度之间的关系.
主要方法:
- 在90名MDD患者和90名健康对照中使用ELISA测量了血清ANXA3度.
- 抑郁症的严重程度使用贝克抑郁症清单 (BDI) 进行评估.
- 分析了ANXA3水平与各种临床和实验室参数之间的相关性.
主要成果:
- 与对照组相比,MDD患者的血清ANXA3水平显著降低 (p < 0.001).
- 血清ANXA3水平与中性粒细胞计数,血小板计数,中性粒细胞与淋巴细胞比率 (NLR),葡萄糖,肌素和ALT负相关.
- 低ANXA3水平,高NLR和葡萄糖失调是更严重抑郁症的预测因素.
- ROC分析表明,ANXA3对中度至重度的MDD具有很高的区分能力 (AUC>0.90).
结论:
- 在MDD患者中,血清ANXA3水平显著降低.
- ANXA3可以作为抑郁症严重程度的潜在生物标志物.
- 需要进一步的研究来确定临床效用和性质 (状态与特征) 在抑郁症ANXA3变化.
更多相关视频
相关概念视频
Depression: Overview
794
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
794
Depressive Disorders: Etiology
444
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
444
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Depressive Disorders: MDD and Dysthymia
664
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
664
Human Genetics
1.5K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.5K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K


